Yasuhiro Oki, Kevin R Kelly, Ian Flinn, Manish R. Patel, Robert Gharavi, Anna Ma, Jefferson Parker, Amir Hafeez, David Tuck, Anas Younes. CUDC-907 in relapsed/refractory diffuse large B-cell lymphoma, including patients with MYC-alterations: results from an expanded phase I trial. haematol [Internet]. 2017Oct.27 [cited 2024Apr.20];102(11):1923-30. Available from: https://haematologica.org/article/view/8255